Drugs of Abuse (DOA) Testing Market Report Provides Insights Into Market Evolution And Growth Prospects

The drugs of abuse (DOA) testing market is poised for significant expansion in the coming years, driven by evolving workplace requirements and technological advancements. As drug testing becomes increasingly integral to various sectors, the industry is set to experience robust growth fueled by new testing methods and enhanced data integration.

Forecasted Growth and Market Size of the Drugs of Abuse Testing Market
By 2030, the drugs of abuse testing market is anticipated to reach a value of $12.17 billion, growing at a compound annual growth rate (CAGR) of 8.8%. This upward trajectory is largely supported by the rising need for drug testing in remote work environments, the increasing use of oral fluid testing methods, and advancements in real-time data collection and integration. Additionally, the enforcement of stricter regulations and the expansion of public health monitoring initiatives are playing a substantial role in propelling the market forward. Key trends shaping this growth include the broader adoption of workplace drug screening programs, a surge in demand for rapid point-of-care testing, the development of multi-panel drug testing kits, heightened reliance on laboratory confirmation testing, and the integration of digital reporting and data management systems.

The drugs of abuse (doa) testing market size has grown strongly in recent years. It will grow from $7.97 billion in 2025 to $8.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to workplace safety regulations, substance abuse prevalence, criminal justice screening needs, immunoassay testing adoption, laboratory infrastructure expansion.

Download a free sample of the drugs of abuse (doa) testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Players Driving the Drugs of Abuse Testing Industry
Several prominent companies dominate the drugs of abuse testing market, including Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, and Aegis Sciences Corporation. Other notable players are NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., and Forensic Fluids Laboratories.

Strategic Expansion Moves in the Market
In June 2024, Premier Biotech Inc., a biotechnology firm based in the United States, acquired Desert Tox LLC. This acquisition, for an undisclosed sum, is aimed at expanding Premier Biotech's lineup of cost-effective drug misuse screening products. Desert Tox LLC specializes in toxicology and drug testing services, and this partnership is expected to enhance the accessibility and efficiency of drug testing offerings across the market.

View the full drugs of abuse (doa) testing market report:
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations and Technological Trends in the Drugs of Abuse Testing Sector
Key companies in the drugs of abuse testing field are increasingly investing in novel solutions such as software-as-a-service (SaaS) platforms. These cloud-based applications, operated by external providers and accessible via the internet, streamline testing procedures, improve data handling, and strengthen competitive advantages in the market. For example, in December 2023, Merck KGaA, a U.S.-based science and technology company, introduced Addison-a sophisticated drug discovery software platform that combines computer-aided drug design, machine learning, and generative AI. This innovative platform offers virtual molecule synthesis recommendations, connects digital drug design with practical manufacturing insights, and uncovers hidden patterns in large datasets. The ultimate goal is to speed up drug development and increase the chances of creating effective new therapies.

Market Segmentation Overview of the Drugs of Abuse Testing Industry
The drugs of abuse testing market is segmented into several categories for a comprehensive analysis:
1) Product and Service: This includes analyzers, rapid testing devices, consumables, and laboratory services.
2) Sample Type: Testing can be performed on urine, hair, oral fluid, and breath samples.
3) Application: The market serves areas such as pain management, criminal justice, and workplace screening.
4) End User: Key users include hospitals, diagnostic laboratories, forensic laboratories, and other relevant organizations.

Further breakdown of the segments includes:
- Analyzers: Immunoassay analyzers, chromatography-based analyzers, and mass spectrometry systems.
- Rapid Testing Devices: Urine test kits, saliva test kits, and hair test kits.
- Consumables: Test strips, reagents, and sample collection devices.
- Laboratory Services: Toxicology testing, confirmation testing, and screening services.

These detailed classifications help provide a clearer picture of the various components that drive the drugs of abuse testing market forward.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.